vs
Side-by-side financial comparison of LifeMD, Inc. (LFMD) and Lifeway Foods, Inc. (LWAY). Click either name above to swap in a different company.
LifeMD, Inc. is the larger business by last-quarter revenue ($60.2M vs $55.4M, roughly 1.1× Lifeway Foods, Inc.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -6.3%, a 10.9% gap on every dollar of revenue. On growth, Lifeway Foods, Inc. posted the faster year-over-year revenue change (18.0% vs 13.0%). LifeMD, Inc. produced more free cash flow last quarter ($-944.4K vs $-17.4M). Over the past eight quarters, LifeMD, Inc.'s revenue compounded faster (24.8% CAGR vs 11.4%).
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
LFMD vs LWAY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $60.2M | $55.4M |
| Net Profit | $-3.8M | $2.5M |
| Gross Margin | 87.7% | 27.8% |
| Operating Margin | -3.3% | 6.8% |
| Net Margin | -6.3% | 4.6% |
| Revenue YoY | 13.0% | 18.0% |
| Net Profit YoY | 18.3% | 1688.1% |
| EPS (diluted) | — | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $55.4M | ||
| Q3 25 | $60.2M | $57.1M | ||
| Q2 25 | $62.7M | $53.9M | ||
| Q1 25 | $64.1M | $46.1M | ||
| Q4 24 | — | $46.9M | ||
| Q3 24 | $53.3M | $46.1M | ||
| Q2 24 | $50.7M | $49.2M | ||
| Q1 24 | $44.1M | $44.6M |
| Q4 25 | — | $2.5M | ||
| Q3 25 | $-3.8M | $3.5M | ||
| Q2 25 | $-1.6M | $4.2M | ||
| Q1 25 | $-183.8K | $3.5M | ||
| Q4 24 | — | $-160.0K | ||
| Q3 24 | $-4.7M | $3.0M | ||
| Q2 24 | $-6.9M | $3.8M | ||
| Q1 24 | $-6.8M | $2.4M |
| Q4 25 | — | 27.8% | ||
| Q3 25 | 87.7% | 28.7% | ||
| Q2 25 | 88.1% | 28.6% | ||
| Q1 25 | 86.5% | 23.9% | ||
| Q4 24 | — | 25.3% | ||
| Q3 24 | 90.6% | 25.7% | ||
| Q2 24 | 90.1% | 27.0% | ||
| Q1 24 | 89.6% | 25.8% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | -3.3% | 8.8% | ||
| Q2 25 | -0.7% | 10.8% | ||
| Q1 25 | 1.5% | 3.4% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | -7.5% | 9.1% | ||
| Q2 24 | -12.4% | 11.0% | ||
| Q1 24 | -14.0% | 8.0% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | -6.3% | 6.2% | ||
| Q2 25 | -2.6% | 7.9% | ||
| Q1 25 | -0.3% | 7.7% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | -8.7% | 6.5% | ||
| Q2 24 | -13.6% | 7.7% | ||
| Q1 24 | -15.3% | 5.4% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | $-0.05 | $0.28 | ||
| Q1 25 | $-0.02 | $0.23 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | $-0.13 | $0.19 | ||
| Q2 24 | — | $0.25 | ||
| Q1 24 | — | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $5.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3M | $85.8M |
| Total Assets | $66.0M | $105.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | $36.2M | $21.2M | ||
| Q1 25 | $34.4M | $19.4M | ||
| Q4 24 | — | $16.7M | ||
| Q3 24 | $37.6M | $20.6M | ||
| Q2 24 | $35.7M | $14.6M | ||
| Q1 24 | $35.1M | $12.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $15.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.5M |
| Q4 25 | — | $85.8M | ||
| Q3 25 | $1.3M | $82.8M | ||
| Q2 25 | $-1.8M | $78.7M | ||
| Q1 25 | $-2.3M | $74.2M | ||
| Q4 24 | — | $71.9M | ||
| Q3 24 | $-7.7M | $71.5M | ||
| Q2 24 | $-4.2M | $68.0M | ||
| Q1 24 | $-845.3K | $63.5M |
| Q4 25 | — | $105.6M | ||
| Q3 25 | $66.0M | $109.5M | ||
| Q2 25 | $73.6M | $98.3M | ||
| Q1 25 | $73.6M | $93.7M | ||
| Q4 24 | — | $90.5M | ||
| Q3 24 | $72.6M | $91.3M | ||
| Q2 24 | $63.8M | $84.9M | ||
| Q1 24 | $61.5M | $82.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-147.1K | $267.0K |
| Free Cash FlowOCF − Capex | $-944.4K | $-17.4M |
| FCF MarginFCF / Revenue | -1.6% | -31.5% |
| Capex IntensityCapex / Revenue | 1.3% | 31.9% |
| Cash ConversionOCF / Net Profit | — | 0.11× |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | $-16.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $267.0K | ||
| Q3 25 | $-147.1K | $6.9M | ||
| Q2 25 | $8.6M | $3.9M | ||
| Q1 25 | $3.1M | $-150.0K | ||
| Q4 24 | — | $-2.6M | ||
| Q3 24 | $6.7M | $7.5M | ||
| Q2 24 | $4.5M | $6.5M | ||
| Q1 24 | $5.2M | $1.5M |
| Q4 25 | — | $-17.4M | ||
| Q3 25 | $-944.4K | $1.8M | ||
| Q2 25 | $7.8M | $1.6M | ||
| Q1 25 | $2.9M | $-2.4M | ||
| Q4 24 | — | $-3.8M | ||
| Q3 24 | $6.3M | $5.9M | ||
| Q2 24 | $3.9M | $5.1M | ||
| Q1 24 | $5.0M | $-923.0K |
| Q4 25 | — | -31.5% | ||
| Q3 25 | -1.6% | 3.1% | ||
| Q2 25 | 12.5% | 3.0% | ||
| Q1 25 | 4.6% | -5.1% | ||
| Q4 24 | — | -8.2% | ||
| Q3 24 | 11.7% | 12.8% | ||
| Q2 24 | 7.7% | 10.4% | ||
| Q1 24 | 11.4% | -2.1% |
| Q4 25 | — | 31.9% | ||
| Q3 25 | 1.3% | 9.0% | ||
| Q2 25 | 1.3% | 4.3% | ||
| Q1 25 | 0.2% | 4.8% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | 0.8% | 3.3% | ||
| Q2 24 | 1.3% | 2.9% | ||
| Q1 24 | 0.4% | 5.5% |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 1.96× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | -0.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.50× | ||
| Q2 24 | — | 1.73× | ||
| Q1 24 | — | 0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFMD
| Telehealth Subscription Revenue | $27.3M | 45% |
| Telehealth | $20.0M | 33% |
| Work Simpli Revenue | $12.9M | 21% |
| Product And Services | $2.5M | 4% |
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
